Selective SIRT2 inhibitors as promising anticancer therapeutics: An update from 2016 to 2020
Eslam Roshdy, Muhamad Mustafa, Abd El-Rahman Shaltout, Mohamed O. Radwan, Mahmoud A. A. Ibrahim, Mahmoud E. S. Soliman, Mikako Fujita, Masami Otsuka, Taha F. S. Ali
Topics & Concepts
SIRT2SirtuinChemistryCarcinogenesisCancerComputational biologyCancer researchPharmacologyEnzymeBiochemistryBiologyGeneGeneticsNAD+ kinaseSirtuins and Resveratrol in MedicinePARP inhibition in cancer therapyAutophagy in Disease and Therapy